Nahid Bemanadicover image
Nahid Bemanadiavatar

Nahid Bemanadi

Living in : Iran
Academic Profile
Posts

Contact Information

-Email
logo
13297f42-c52f-4bd3-8d0e-45b62c6d7ea9ApplyChance Link

Educations

Sharif University of Technology logo
Organic ChemistryMaster'sSharif University of Technology2017-07-21 Iran
Supervisor's name :Dr. Hamidreza kalhor
Title :
Design and construction of novel intein-mediated biosensor in order to detect amyloid fibrils.
Kharazmi University logo
ChemistryBachelor'sKharazmi University2013-07-01 Iran

Work Experiences

Research Assistant
I am currently working in this role
Master’s Thesis Research
Start : 01-Dec-2015
End : 01-Dec-2017
Master’s Thesis Research
Start : 01-Dec-2015
End : 01-Dec-2017

Journal Publications

Publication Title :
A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccineFourth author
Link :
Publication Title :
A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccineFourth author
Link :
Publication Title :
A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccineFourth author
Link :
Publication Title :
A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccineFourth author
Link :
Publication Title :
Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockadeFirst author
Link :
Publication Title :
Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockadeFirst author
Link :
Publication Title :
Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockadeFirst author
Link :
Publication Title :
Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment in a murine papillomavirus tumor modelThird author
Link :
Publication Title :
Epigenetic reprogramming mechanisms of immunity during influenza A virus infection.First author
Link :
Publication Title :
Role of Myeloid-derived suppressor cells in viral respiratory infections; Hints for Discovering Therapeutic Targets for COVID-19.First author
Link :
Publication Title :
Role of  T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches.First author
Link :
Publication Title :
CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy.First author
Link :
Publication Title :
The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?First author
Link :
Publication Title :
Higher prevalence of asymptomatic or mild COVID‐19 in children, claims and cluesFirst author
Link :
Publication Title :
Virotheranostics, A Double-barreled Viral Gun Pointed toward Cancer; Ready to Shoot?First author
Link :
Publication Title :
Oncolytic paramyxoviruses- induced autophagy; a prudent weapon for cancer therapyThird author
Link :
Publication Title :
Inactivation methods for whole influenza vaccine production.Second author
Link :

Research Keywords

cancer immunotherapy
Cancer Biology and Immunology
Oncolytic Virotherapy
Molecular and Cellular Biochemistry
Development of Protein-based Biomedical Tools

Awards

First Rank Student in UniversityMaster